Figure 4.
Figure 4. Lifespan of circulating RBCs and accumulation of hemosiderin in the spleen of SHPS-1 mutant mice. (A) WT (○) or homozygous SHPS-1 mutant (•) mice were injected intravenously with CFSE-labeled RBCs derived from WT (left) or homozygous SHPS-1 mutant (right) mice. Blood samples (5 μL) were collected from a tail vein at the indicated times thereafter, and the fraction of fluorescent RBCs among recipient RBCs (100 000 per sample) was determined by flow cytometry. Data are expressed as a percentage of the value determined 5 minutes after injection and are means ± SE of values from 5 recipients per group. The percentage of CFSE-positive RBCs at 5 minutes after injection was 7% to 10% of total RBCs determined. (B) Spleen sections from WT or SHPS-1 mutant mice at 6 weeks of age were fixed with paraformaldehyde and stained with Berlin blue. Scale bar, 0.5 mm. Image acquisition performed as described for Figure 2C.

Lifespan of circulating RBCs and accumulation of hemosiderin in the spleen of SHPS-1 mutant mice. (A) WT (○) or homozygous SHPS-1 mutant (•) mice were injected intravenously with CFSE-labeled RBCs derived from WT (left) or homozygous SHPS-1 mutant (right) mice. Blood samples (5 μL) were collected from a tail vein at the indicated times thereafter, and the fraction of fluorescent RBCs among recipient RBCs (100 000 per sample) was determined by flow cytometry. Data are expressed as a percentage of the value determined 5 minutes after injection and are means ± SE of values from 5 recipients per group. The percentage of CFSE-positive RBCs at 5 minutes after injection was 7% to 10% of total RBCs determined. (B) Spleen sections from WT or SHPS-1 mutant mice at 6 weeks of age were fixed with paraformaldehyde and stained with Berlin blue. Scale bar, 0.5 mm. Image acquisition performed as described for Figure 2C.

Close Modal

or Create an Account

Close Modal
Close Modal